Healthcare
Rising diabetes cases propel medical devices market toward 8.1% CAGR through 2034
Rising diabetes cases propel medical devices market toward 8.1% CAGR through 2034
The industry is projected to reach $67.39b by end-period.
IHH Healthcare bets on Fortis stake for Indian expansion
It plans to add 2,000 hospital beds by 2028.
Singapore's Health ministry grants $78.9m in first tranche of community care pay rise
Salary guidelines provided at least a 7% increase.
AI in precision medicine market to soar to $38.9B by 2034 on 35.5% CAGR
Market growth is driven by ML, deep learning, EHR.
Ping An Good Doctor projected to see 56% profit CAGR surge by 2027
Ali Health adjusted net profit forecast at 24% CAGR.
Neurocosmetics reshape skincare as 79% favour natural tags
A GlobalData survey showed rising interest in stress-linked skin solutions.
Global respiratory care market to hit $47.9b as AI transforms home treatment
Respiratory care revenue is set to surge as portable oxygen and smart ventilators reach homes.
IHH, Fortis drive India’s health-tech startups towards deployment
Three-month programme moves startups beyond pilots.
Radiopharma market to hit $21.8b by 2033 on cancer therapy boom
The Asia-Pacific region is projected to have the highest growth rate.
Medical fibre optics to hit $1.5b by 2030 as minimally invasive surgery surges
The 6.2% CAGR reflects global growth in high-resolution diagnostic fibres and biomedical sensing.
Medical simulation market set to reach $7.23b by 2030
Forecast implies 15.6% annual growth.
Health sterotypes block early preventative actions amongst Asians: AIA
Rigid beliefs discourage early health action across Asia.
AI, chatbots cut nurse paperwork burdens
Hospitals are deploying barcoding and digital booking tools to relieve staffing strain.
SMART and NUS weaponize AI to give soft robots human-like reflexes
The system reduced tracking error by 44% to 55% under heavy disturbances.
$2.17b AI surge projected by 2034 amidst pursuit to end missed cancer diagnoses
Asia-Pacific drives the fastest growth.
China captures 49% of global drug deals in 2025 amidst lower costs, faster timelines
This is an improvement from only 6% in 2020.
Strong pipeline, M&A activity could trigger rapid earnings for Greater China's healthcare firms: UOB
The industry is expected to become a key international player.
Most Read
1. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 2. Neurological disorders and aging boost brain-computer interface market 3. Cardiac monitoring devices market to hit $37.88b by 2031 4. AJJ Medtech hits $8m order book with $3m green supply deal 5. Global prescription drugs market to reach $2.26t by 2034Resource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation